Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.0799
-0.0065 (-7.52%)
Nov 10, 2026, 3:03 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €12.71 thousand as of November 10, 2026. It is the 51,745th most valuable company in the world and the 692nd biggest in France. Its market cap has decreased by 32.40% in one year.
Market Cap
12.71K
Enterprise Value
144.86K
Revenue
810.20K
Global Rank
Country Rank
#692 France
PE Ratio
n/a
ChartMarket Cap Chart
Since June 2, 2025, Neovacs's market cap has decreased from 600.00K to 12.71K, a decrease of -97.88%. That is a compound annual growth rate of -93.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 14.55K | 255.93% |
| Dec 31, 2025 | 4.09K | -99.32% |
| Jun 2, 2025 | 600.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biophytis | 14.84M |
| Aelis Farma | 13.87M |
| TME Pharma | 10.09M |
| Advicenne | 9.17M |
| Poxel | 8.17M |
| Aton | 5.80M |
| Quantum Genomics Société Anonyme | 5.02M |
| Oncodesign Precision Medicine Société anonyme | 4.57M |